Form 8-K - Current report:
SEC Accession No. 0000950170-25-024833
Filing Date
2025-02-21
Accepted
2025-02-21 16:05:10
Documents
11
Period of Report
2025-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20250214.htm   iXBRL 8-K 48352
  Complete submission text file 0000950170-25-024833.txt   165041

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20250214.xsd EX-101.SCH 29466
13 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20250214_htm.xml XML 4508
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 25651678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)